Fishing Martha's 

Vineyard 

with 

Captain Chris Peters

Merck announce strategic collaboration to develop novel antibody therapeutics AnaptysBio.

AnaptysBio, Merck announce strategic collaboration to develop novel antibody therapeutics AnaptysBio, Inc ed treatment ., a privately-held therapeutic antibody system and product company, today announced a strategic collaboration with Merck, through an affiliate marketer, to develop novel antibody therapeutics to a specified disease target. Merck shall receive worldwide privileges to develop and commercialize antibodies optimized by AnaptysBio. AnaptysBio provides received an upfront sum and can be permitted receive milestone royalties and obligations associated with the development and sale of any products produced from the collaboration.575 million Anavex Lifestyle Sciences Corp.